EGR1 and breast carcinoma: Silencing of EGR-1 with syntactic catalytic DNA has been reported to inhibit human breast carcinoma proliferation and migration [97], while on the other hand downregulation of gelsolin (indicator of breast cancer) has been correlated with suppression of EGR-1 [98].